EVO · Evotec SE

Evotec SE announced a planned CFO transition. Paul Hitchin will step down on April 30, 2026, for personal reasons unrelated to the company. The Supervisory Board accepted his decision and thanked him for his leadership since March 1, 2025, during which he guided the company through a significant financial and strategic evolution. Claire Hinshelwood will succeed him as CFO effective May 1, 2026. Hinshelwood brings over 30 years of financial leadership experience, most recently as Group CFO of BMI Group, where she transformed financial operations and improved the company's financial position during challenging market conditions. She also held senior finance roles at Novartis and Syngenta. The transition appears orderly and is not expected to disrupt Evotec's strategic direction. CEO Dr. Christian Wojczewski expressed confidence in Hinshelwood's ability to advance the company's near- and mid-term goals toward increased profitability and sustainable growth. No compensation details or changes to financial guidance were disclosed.